RELEASE OF 5-AMINOSALICYLIC ACID FROM PENTASA DURING NORMAL AND ACCELERATED INTESTINAL TRANSIT-TIME

被引：29
|
作者：
CHRISTENSEN, LA
SLOT, O
SANCHEZ, G
BOSERUP, J
RASMUSSEN, SN
BONDESEN, S
HANSEN, SH
HVIDBERG, EF
机构：
[1] UNIV COPENHAGEN,RIGSHOSP,DEPT CLIN PHARMACOL 3124,9 BLEGDAMSVEJ,DK-2100 COPENHAGEN O,DENMARK
[2] AALBORG HOSP,DEPT MED GASTROENTEROL,DK-9000 AALBORG,DENMARK
[3] ROYAL DANISH SCH PHARM,DEPT ORGAN CHEM,DK-2100 COPENHAGEN O,DENMARK
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 23卷 / 03期
关键词：
D O I：
10.1111/j.1365-2125.1987.tb03061.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：365 / 369
页数：5
相关论文
共 50 条
  • [21] Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride - P(CBFAS)
    Cai, QX
    Zhu, KJ
    Chen, D
    Gao, LP
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (02) : 203 - 208
  • [22] INFLUENCE OF HYDROPHILIC ADDITIVES ON 5-AMINOSALICYLIC ACID RELEASE RATE FROM MATRIX PELLETS
    DEBRANT, V
    REMON, JP
    5TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, 1989, : 222 - 230
  • [23] THE TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL-DISEASES WITH 5-AMINOSALICYLIC ACID
    MALCHOW, H
    INTERNIST, 1987, 28 (01): : 14 - 20
  • [24] Obtaining the palygorskite:chitosan composite for modified release of 5-aminosalicylic acid
    Gramoza Vilarinho Santana, Ana Cristina Sousa
    Soares Sobrinho, Jose Lamartine
    da Silva Filho, Edson Cavalcanti
    Cunha Nunes, Livio Cesar
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 73 : 245 - 251
  • [25] THE RELEASE PROFILE OF A CONTROLLED RELEASE PREPARATION OF 5-AMINOSALICYLIC ACID (ROWASA I) IN HUMANS
    MCLEOD, RS
    COHEN, Z
    VARI, BJ
    BLAIR, JE
    GREENBERG, GR
    DISEASES OF THE COLON & RECTUM, 1990, 33 (01) : 21 - 25
  • [26] Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
    Adeyinka Abinusawa
    Srini Tenjarla
    Advances in Therapy, 2015, 32 : 477 - 484
  • [27] Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
    Abinusawa, Adeyinka
    Tenjarla, Srini
    ADVANCES IN THERAPY, 2015, 32 (05) : 477 - 484
  • [28] SLOW-RELEASE 5-AMINOSALICYLIC ACID THERAPY IN CHILDREN WITH SMALL-INTESTINAL CROHNS-DISEASE
    GRIFFITHS, A
    KOLETZKO, S
    SYLVESTER, F
    MARCON, M
    SHERMAN, P
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1993, 17 (02): : 186 - 192
  • [29] Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid
    Batta, AK
    Tint, GS
    Xu, GR
    Shefer, S
    Salen, G
    JOURNAL OF LIPID RESEARCH, 1998, 39 (08) : 1641 - 1646
  • [30] DOES PROLONGED COLONIC TRANSIT IMPAIR THE EFFICACY OF ORAL 5-AMINOSALICYLIC ACID FORMULATIONS
    RILEY, SA
    TAVARES, IA
    BENNETT, A
    MANI, V
    GUT, 1991, 32 (05) : A556 - A557
12345